Home > Pharmalucence Salary

Pharmalucence Salary

  • 41
  • 61
  • 95
Pharmalucence average salary is $72,000, median salary is $72,000 with a salary range from $60,000 to $84,000.
Pharmalucence salaries are collected from government agencies and companies. Each salary is associated with a real job position. Pharmalucence salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 2 Pharmalucence Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Robotics Engineer 60,000-60,000 Ithaca, NY, 14850 2016 Pharmalucence Robotics Engineer Salaries (2)
Pharmalucence Ithaca, NY Salaries
Robotics Engineer 84,000-84,000 Austin, TX, 73301 2016 Pharmalucence Robotics Engineer Salaries (2)
Pharmalucence Austin, TX Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Pharmalucence salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Pharmalucence Jobs
See more Pharmalucence Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Pharmalucence... Information
  • Pharmalucence, Inc
  • Industry: BioTech/Drugs
  • City: Bedford, MA
  • Pharmalucence traces its roots to CIS-US, Inc., the U. S. subsidiary of CIS bio international, itself an asset of CEA headquartered in Paris, France. CIS-US was incorporated in 1985 to commercialize medical applications derived from isotopic technologies developed by its French ownership. In the late 1980¡¯s, the company acquired a production facility in Bedford, MA, establishing itself as a U. S. manufacturer of radiopharmaceuticals and medical devices.Between 1999 and 2007, CIS-US passed through three ownership changes, culminating in an employee privatization.